Work

Supplementary Figure S3 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC

Year: 2026

Type: supplementary-materials

Abstract: Kaplan–Meier curves for OS (left column) and PFS (right column), stratified by PET response status (non-responder vs responder), treatment modality (proton vs photon), durvalumab use (durvalumab vs no durvalumab), histology (adenocarcinoma vs squamous cell carcinoma and other), and chemotherapy regimen (carboplatin + paclitaxel vs other).

DOI: 10.1158/1078-0432.33252867

Authors: Jing Zeng, Sunan Cui, Daniel S. Hippe, Jie Fu, Faisal Yaseen, Yulun He, John Kang, Clemens Grassberger, Hubert J. Vesselle, Paul E. Kinahan, Keith D. Eaton, Christina S. Baik, Rafael Santana-Davila, Sylvia Lee, Ramesh Rengan, Stephen R. Bowen

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7203476898

Cites:

Cited by:

Related to: 10